Evidence map›Paper›PMID 28072824›Full record

ArticlePloS one2017

D19S Mutation of the Cationic, Cysteine-Rich Protein PAF: Novel Insights into Its Structural Dynamics, Thermal Unfolding and Antifungal Function.

Christoph Sonderegger, Ádám Fizil, Laura Burtscher, Dorottya Hajdu, Alberto Muñoz, Zoltán Gáspári, Nick D Read, Gyula Batta, Florentine Marx

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. TheJournal of fungi (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. TheJournal of fungi (Basel, Switzerland) · 2020
    Article
  13. Review
  14. Article
  15. Antimicrobial agents and chemotherapy · 2019
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Three Antifungal Proteins FromFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Christoph SondereggerDivision of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-8408-1842
Ádám FizilDepartment of Organic Chemistry, Faculty of Science and Technology, University of Debrecen, Debrecen, Hungary.
Laura BurtscherDivision of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Dorottya HajduDepartment of Organic Chemistry, Faculty of Science and Technology, University of Debrecen, Debrecen, Hungary.
Alberto MuñozManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.
Zoltán GáspáriFaculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary.
Nick D ReadManchester Fungal Infection Group, Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.
Gyula BattaDepartment of Organic Chemistry, Faculty of Science and Technology, University of Debrecen, Debrecen, Hungary.
Florentine MarxDivision of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Innsbruck Medical University · ATUniversity of Debrecen · HUUniversity of Manchester · GBPázmány Péter Catholic University · HU

Funding

Austrian Science Fund FWF I 1644Austrian Science Fund FWF P 25894
6 · The paper itself

Abstract

The cysteine-rich, cationic, antifungal protein PAF is abundantly secreted into the culture supernatant of the filamentous Ascomycete Penicillium chrysogenum. The five β-strands of PAF form a compact β-barrel that is stabilized by three disulphide bonds. The folding of PAF allows the formation of four surface-exposed loops and distinct charged motifs on the protein surface that might regulate the interaction of PAF with the sensitive target fungus. The growth inhibitory activity of this highly stable protein against opportunistic fungal pathogens provides great potential in antifungal drug research. To understand its mode of action, we started to investigate the surface-exposed loops of PAF and replaced one aspartic acid at position 19 in loop 2 that is potentially involved in PAF active or binding site, with a serine (Asp19 to Ser19). We analysed the overall effects, such as unfolding, electrostatic changes, sporadic conformers and antifungal activity when substituting this specific amino acid to the fairly indifferent amino acid serine. Structural analyses revealed that the overall 3D solution structure is virtually identical with that of PAF. However, PAFD19S showed slightly increased dynamics and significant differences in the surface charge distribution. Thermal unfolding identified PAFD19S to be rather a two-state folder in contrast to the three-state folder PAF. Functional comparison of PAFD19S and PAF revealed that the exchange at residue 19 caused a dramatic loss of antifungal activity: the binding and internalization of PAFD19S by target cells was reduced and the protein failed to trigger an intracellular Ca2+ response, all of which are closely linked to the antifungal toxicity of PAF. We conclude that the negatively charged residue Asp19 in loop 2 is essential for full function of the cationic protein PAF.

Indexed as

Molecular Dynamics SimulationMutation, MissenseProtein DenaturationAmino Acid MotifsAntifungal AgentsBinding SitesCalciumCysteineFungal ProteinsPenicillium chrysogenumProtein BindingAntifungal AgentsCalciumCysteineFungal ProteinsPAF protein, Penicillium chrysogenum

Identifiers

PMID28072824
PMCPMC5224997
OpenAlexW2568204381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.